Artemether/Lumefantrine for the Treatment of P. malariae in a Patient on Hemodialysis
The combination of artemether/lumefantrine is indicated for the treatment of acute uncomplicated Plasmodium falciparum malaria. There have been no clinical trials to assess the efficacy of this medication in patients with renal impairment. While it is unlikely that artemether/lumefantrine would be r...
Main Authors: | Rita Patrocínio-Jesus, João Cunha, Diva Trigo, Bárbara Flor-de-Lima, Patrícia Pacheco |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2019/1326171 |
Similar Items
-
The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria.
by: Quique Bassat
Published: (2011-12-01) -
Efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Nepal
by: Prakash Ghimire, et al.
Published: (2018-08-01) -
Malaria case-management under artemether-lumefantrine treatment policy in Uganda
by: Ssekitooleko James, et al.
Published: (2008-09-01) -
Genomic Characterization of Recrudescent Plasmodium malariae after Treatment with Artemether/Lumefantrine
by: Gavin G. Rutledge, et al.
Published: (2017-08-01) -
Implementation of artemether-lumefantrine treatment policy for malaria at health facilities in Tanzania
by: Mugoyela V, et al.
Published: (2011-09-01)